top of page

Our Physicians

Munsaf.jpg

Swapnil D. Munsaf, MD

EDUCATION

May 2003
Bachelor of Arts, Biology and Psychology

University of Rochester

May 2007

Doctor of Medicine

University of Rochester

 

May 2010

Residency in Internal Medicine

University of Rochester Medical Center

 

June 2013

Fellowship in Gastroenterology

State University of New York at Buffalo

 

June 2014

Advanced Therapeutic Endoscopy Fellowship

University of Massachusetts Memorial Medical Center

BOARD CERTIFICATIONS

2013  American Board of Internal Medicine

2010  American Board of Gastroenterology

LICENSURE

Connecticut Medical License: #53046

APPOINTMENTS

2013 – Present

Assistant Professor of Medicine

University of MA - Worcester

HOSPITAL AFFILIATION

2013 – Present

Attending Physician

Department of Gastroenterology

University of Massachusetts Memorial Medical Center

University of Massachusetts - Worcester

 

2013 – Present

Assistant Professor of Medicine 

Department of Medicine, Gastroenterology

University of Massachusetts - Worcester

HONORS & AWARDS

  • Awarded Interventional Endoscopy Course Grants

  • University of Rochester Rush Rhees Scholarship

  • Rochester Early Medical Scholars Program

  • Dean’s List all semesters University of Rochester

PROFESSIONAL ORGANIZATIONS

Professional Memberships:

American Society of Gastrointestinal Endoscopy

American Gastroenterology Association

American College of Gastroenterology

American College of Physicians

PUBLICATION

Munsaf SD; Rani A. 

Significance of Incidental Thickening of the Upper GI Tract on Computed Tomography

Presented at DDW National Conference: May 2013.

 

Munsaf SD; Maliakkal B; Mantry PS.

Renal Impairment in Cirrhotic Patients Undergoing CT Scans with Intravenous Contrast Agents. 

Presented at ASLD National Conference: October 2006.

 

Mantry PS; Munsaf SD.

Rifaximin for the Treatment of Hepatic Encephalopathy. 

Transplant Proceedings. December 2010; 42(10):4543-7

 

Mantry PS; Munsaf SD.

Comparison of Tolerability of Adjunctive Rifaximin Treatment Versus Lactulose Monotherapy for Hepatic Encephalopathy. 

Presented at ASLD National Conference: October 2008.

 

Mantry PS; Munsaf SD.

Analysis of the Effect of Rifaximin Plus Lactulose on Hospitalizations in Patients With End-Stage Liver Disease. 

Presented at ASLD National Conference: October 2008.

 

Mantry PS; Munsaf SD.

Does the Addition of Rifaximin to Lactulose Reduce the Severity of Hepatic Encephalopathy? A Single-Center Experience. 

Presented at ASLD National Conference: October 2008.

bottom of page